Keywords: roche, earnings, hit, new, heights, humer, defends
Roche earnings hit new heights, Humer defends development pipeline
Article | 17 August 2000
Roche of Switzerland has posted strong growth for the first half of2000, with sales reaching 14.8 billion Swiss francs ($8.65 billion), up 10%, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
